BCL2 and cancer: By elevating Bax and Caspase 3 levels and concurrently downregulating the anti-apoptotic protein BCL-2, HSP demonstrated an inhibitory effect on human cancer cell HT-29 through the induction of mitochondrial-mediated apoptosis [158].